Dissecting the molecular landscape of pancreatic cancer

towards a precision medicine approach

Antonio Pea, Liang Cheng, Claudio Luchini

Research output: Contribution to journalArticle

Abstract

Introduction: Pancreatic cancer is a highly malignant disease with an increasing incidence. Most patients with this type of neoplasm present with unresectable tumors at the time of diagnosis. Areas covered: Current treatments for such patients are minimally effective in controlling cancer progression; therefore, alternative therapeutic approaches are needed to improve clinical outcomes. Thanks to the growing body of knowledge on the genetic landscape of pancreatic cancer, the application of the so-called ‘precision medicine’, a new approach that considers the individual variability in molecular alterations to improve oncological outcomes by personalizing cancer treatment, could be now possible for some patients. Expert opinion: In this review, we will discuss the most recent investigative studies, as well as their primary results, of the potential role of precision medicine in the treatment of pancreatic cancer.

Original languageEnglish (US)
JournalExpert Review of Precision Medicine and Drug Development
DOIs
StatePublished - Jan 1 2019

Fingerprint

Precision Medicine
Pancreatic Neoplasms
Neoplasms
Expert Testimony
Therapeutics
Incidence

Keywords

  • cancer genomics
  • molecular alterations
  • Pancreatic cancer
  • personalized treatment
  • precision medicine
  • targeted therapy

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Pharmacology
  • Drug Discovery

Cite this

@article{9cb6fad431264257a4774d60fba0b781,
title = "Dissecting the molecular landscape of pancreatic cancer: towards a precision medicine approach",
abstract = "Introduction: Pancreatic cancer is a highly malignant disease with an increasing incidence. Most patients with this type of neoplasm present with unresectable tumors at the time of diagnosis. Areas covered: Current treatments for such patients are minimally effective in controlling cancer progression; therefore, alternative therapeutic approaches are needed to improve clinical outcomes. Thanks to the growing body of knowledge on the genetic landscape of pancreatic cancer, the application of the so-called ‘precision medicine’, a new approach that considers the individual variability in molecular alterations to improve oncological outcomes by personalizing cancer treatment, could be now possible for some patients. Expert opinion: In this review, we will discuss the most recent investigative studies, as well as their primary results, of the potential role of precision medicine in the treatment of pancreatic cancer.",
keywords = "cancer genomics, molecular alterations, Pancreatic cancer, personalized treatment, precision medicine, targeted therapy",
author = "Antonio Pea and Liang Cheng and Claudio Luchini",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/23808993.2019.1604135",
language = "English (US)",
journal = "Expert Review of Precision Medicine and Drug Development",
issn = "2380-8993",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Dissecting the molecular landscape of pancreatic cancer

T2 - towards a precision medicine approach

AU - Pea, Antonio

AU - Cheng, Liang

AU - Luchini, Claudio

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: Pancreatic cancer is a highly malignant disease with an increasing incidence. Most patients with this type of neoplasm present with unresectable tumors at the time of diagnosis. Areas covered: Current treatments for such patients are minimally effective in controlling cancer progression; therefore, alternative therapeutic approaches are needed to improve clinical outcomes. Thanks to the growing body of knowledge on the genetic landscape of pancreatic cancer, the application of the so-called ‘precision medicine’, a new approach that considers the individual variability in molecular alterations to improve oncological outcomes by personalizing cancer treatment, could be now possible for some patients. Expert opinion: In this review, we will discuss the most recent investigative studies, as well as their primary results, of the potential role of precision medicine in the treatment of pancreatic cancer.

AB - Introduction: Pancreatic cancer is a highly malignant disease with an increasing incidence. Most patients with this type of neoplasm present with unresectable tumors at the time of diagnosis. Areas covered: Current treatments for such patients are minimally effective in controlling cancer progression; therefore, alternative therapeutic approaches are needed to improve clinical outcomes. Thanks to the growing body of knowledge on the genetic landscape of pancreatic cancer, the application of the so-called ‘precision medicine’, a new approach that considers the individual variability in molecular alterations to improve oncological outcomes by personalizing cancer treatment, could be now possible for some patients. Expert opinion: In this review, we will discuss the most recent investigative studies, as well as their primary results, of the potential role of precision medicine in the treatment of pancreatic cancer.

KW - cancer genomics

KW - molecular alterations

KW - Pancreatic cancer

KW - personalized treatment

KW - precision medicine

KW - targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85064598467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064598467&partnerID=8YFLogxK

U2 - 10.1080/23808993.2019.1604135

DO - 10.1080/23808993.2019.1604135

M3 - Article

JO - Expert Review of Precision Medicine and Drug Development

JF - Expert Review of Precision Medicine and Drug Development

SN - 2380-8993

ER -